# OnCo record luca-gianni (person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/people/luca-gianni/>
  a schema:Person ;
  onco:kind "person" ;
  schema:identifier "luca-gianni" ;
  schema:name "Luca Gianni"@en ;
  schema:description "Milan oncologist who led NeoSphere, the trial that showed adding pertuzumab to trastuzumab and docetaxel before surgery clears more HER2-positive breast cancers, the basis for pertuzumab's neoadjuvant approval."@en ;
  schema:url <https://onco.cc/people/luca-gianni/> ;
  schema:dateModified "2026-09-18"^^xsd:date ;
  onco:tag "breast", "neoadjuvant", "trialist" ;
  schema:jobTitle "Medical oncologist and President, Fondazione Michelangelo, Milan" ;
  schema:sameAs <https://orcid.org/0000-0002-2372-9625> ;
  onco:cancers <https://onco.cc/cancers/her2-positive-early-breast-cancer/>, <https://onco.cc/cancers/breast-her2-positive/> ;
  onco:institutions <https://onco.cc/institutions/fondazione-michelangelo/> ;
  onco:trials <https://onco.cc/trials/neosphere/> ;
  schema:affiliation <https://onco.cc/institutions/fondazione-michelangelo/> .